Serum Biomarker Panel for Diagnosis and Prognosis of Pancreatic Ductal Adenocarcinomas

Overview of attention for article published in Frontiers in oncology, July 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

twitter: 3 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 12 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 7,804 followers.

#Serum #Biomarker Panel for #Diagnosis and #Prognosis of #Pancreatic Ductal Adenocarcinomas Read full article: https://t.co/zAGhgDwhb4

18 Nov 2021

Reply Repost Favourite

New article: Serum Biomarker Panel for Diagnosis and Prognosis of Pancreatic Ductal Adenocarcinomas https://t.co/wRlFqaszVX #pancreaticcancer #oncology https://t.co/fV9n7wGXs3

22 Jul 2021

Reply Repost Favourite

New research: Serum Biomarker Panel for Diagnosis and Prognosis of Pancreatic Ductal Adenocarcinomas: Background Patients with pancreatic ductal adenocarcinoma (PDAC) have late diagnosis which results in poor prognosis. Currently, surgical… https://t.co/ch

05 Jul 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.